Ellington Credit (EARN) traded up 2.75 % during a 24 hours period ending at 06:51 PM Central Europe on Tuesday 27th. One Ellington Credit stock can currently be bought for about USD 3.68 on popular exchanges. Current supply of Ellington Credit stocks is 38.2 mn. Ellington Credit has a current market capitalization of USD 139.3 mn and approximately USD 1.5 mn worth of Ellington Credit was traded on exchanges in the last 24 hours. Since last month end, Ellington Credit has traded -11.4 % down. Simple moving average of last 200 days is at USD 4.57. The highest price of past 52 weeks was recorded at USD 5.72 on 01/28/2026. 52 weeks low was at USD 3.22 on 10/14/2026.
Summary of the latest news for Ellington Credit
Ellington Credit Company filed a current report on October 23, 2026 announcing the execution of an equity distribution agreement that allows the trust to offer up to a substantial amount of its common shares through a group of placement agents. The agreement, completed with its adviser and administrator, specifies that the trust may sell shares at prevailing market prices and that agents will receive commissions of up to two percent of sales proceeds. The filing confirms that the trust’s registration statement and prospectus have been declared effective and that the common shares are listed on the New York Stock Exchange under the ticker “EARN.” The report also includes a comprehensive set of representations and warranties covering the trust’s compliance with securities laws, its internal controls, and the absence of material adverse events. No announcement of a sale has yet been made, and the trust states that proceeds will be used for general corporate purposes and future investments.
Here is how related stocks have performed in the past 24 hours:
Akebia Therapeutics (AKBA) traded up 13.58 % and now trades at USD 0.65. Current market capitalisation for Akebia Therapeutics is USD 165.2 mn. Akebia Therapeutics reported that its oral anemia treatment, vadadustat, achieved superiority over traditional erythropoiesis‑stimulating agents in a recent clinical study presented at the American Society of Nephrology Kidney Week. The trial, involving more than two thousand hemodialysis patients, demonstrated a meaningful reduction in the combined endpoint of mortality and hospitalization, primarily driven by fewer hospital admissions. Patients receiving vadadustat also experienced fewer high hemoglobin excursions and a lower need for rescue therapy with conventional agents. Safety data showed a modest decline in serious adverse events compared with the comparator, while rates of high hemoglobin levels were significantly lower. The findings suggest that vadadustat may offer a safer and more effective approach to managing anemia in patients on dialysis.
Emmis Acquisition (EMIS) traded up 0.19 % and now trades at USD 10.3. Emmis Acquisition has a market capitalisation of USD 162.2 mn.
Shutterstock (SSTK) traded down -4.36 % and now trades at USD 4.46. Current market capitalisation for Shutterstock is USD 163.3 mn. Shutterstock Inc. has announced a strategic partnership with a leading social‑media platform to expand its content licensing and distribution. The collaboration aims to integrate Shutterstock’s extensive image and video library with the platform’s advertising ecosystem, allowing creators to monetize visual assets more effectively. Executives noted that the deal will enhance discoverability for Shutterstock’s contributors while offering the platform richer media options for advertisers. The partnership also includes joint efforts to improve content moderation tools and safeguard against copyright infringement. While the agreement does not alter Shutterstock’s core subscription model, it is expected to increase exposure for its media and could influence future licensing terms for third‑party content. The company has stated that it will monitor performance metrics to assess the impact of the alliance on user engagement and revenue growth.
One Nuclear Energy (ONEN) traded down -6.02 % and now trades at USD 1.27. Current market capitalisation for One Nuclear Energy is USD 164.1 mn. On October 26, 2026, ONE Nuclear Energy Inc. filed an amended Schedule 13G/A, reporting a change in ownership that saw a reporting group—HC VII Sponsor LLC and its related entities—beneficially own approximately five to six percent of the company’s common stock. The amendment, filed under Rule 13d‑1(d), reflects a shift in stake that crossed the 10‑percent threshold, prompting a formal exit filing. The joint filing agreement among the reporting parties, signed by managing members Daniel J. Hennessy and Thomas D. Hennessy, confirms each party’s responsibility for timely and accurate disclosure of its holdings. The filing indicates that the reporting persons maintain shared voting and dispositive power over the shares, with Thomas D. Hennessy holding a small additional direct stake. The update underscores the company’s compliance with SEC disclosure requirements while noting a notable adjustment in shareholder structure.
Nmp Acquisition (NMP) traded down -0.1 % and now trades at USD 10.41. Nmp Acquisition has a market capitalisation of USD 166.3 mn.